Transaction

Clearwater advises Naxicap on its divesture of Phythea to Noreva

Transaction

Naxicap sold Phythea to Laboratoires Noreva

Sell-side

Undisclosed

Role

Adviser to Naxicap on the sale of Phythea

Sector

Consumer
Healthcare

Region

France & Belgium

We have advised Naxicap on the divestiture of its portfolio company, Phythea, a designer and distributor of food supplements, to Laboratoires Noreva.

Phythea designs and distributes food supplements, particularly for joints and menopause, through its brands Phytalgic and Menophytea. Its 28 products are distributed in 5,500 pharmacies and parapharmacies, mainly in France, but also in the Antilles and Belgium, generating sales of €9m.

Founded in the 1990s by Yves-Noël Lepoutre and based in Clermont-Ferrand, Laboratoires Noreva specialises in dermo-cosmetics and food supplements through its brands Noreva, Onagrine, Novodex, Nutreov, and Elcea. This acquisition allows Laboratoires Noreva to strengthen its market share in the food supplements sector and reach sales of €40m.

Pythea supplements

Advisers

Transactions